Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Scispot Welcomes In Vivo Research Veteran Dr. Rajan Bawa to Advisory Board


News provided by

Scispot

Jun 28, 2024, 09:30 ET

Share this article

Share toX

Share this article

Share toX

Scispot Welcomes In Vivo Research Veteran Dr. Rajan Bawa to Advisory Board
Scispot Welcomes In Vivo Research Veteran Dr. Rajan Bawa to Advisory Board

Dr. Rajan Bawa Joins Scispot as Scientific Advisor

KITCHENER, ON, June 28, 2024 /PRNewswire-PRWeb/ -- Scispot, a leading life science tech stack provider, proudly welcomes Dr. Rajan Bawa as its latest Scientific Advisor. Dr. Bawa, a serial entrepreneur, founder & former CEO of Care Research, brings a wealth of expertise to the Scispot team. In addition, Dr. Bawa has a solid track record in product and process development as evidenced by several of his innovative contributions that have resulted in marketed products. Further as ex-president of the Rocky Mountain Society of Quality Assurance (a chapter of the International Society of Quality Assurance), Dr. Bawa's insights in complying with and facilitating approval by regulatory agencies will prove invaluable to Scispot. His appointment signals a significant step forward for Scispot as the company creates specialized solutions for in vivo research and vivarium management. Leveraging its expertise, Scispot is set to expand its customer base among major CROs and drug developers by enhancing lab interoperability and integrating in vivo research workflows, facilitating faster and more efficient development of life-saving drugs.

Dr. Bawa's extensive background in in vivo research and pharmaceutical product development complements Scispot's objectives to advance product innovation and refine go-to-market strategies. In his new role, Dr. Bawa will be instrumental in helping create a product tailored for in vivo research and training Scispot AI for animal research workflows and data.

"Scispot's mission to fast-track new drug market entries with digital solutions resonates with my career and biotech passion. I'm excited to contribute to Scispot's efforts, aiming for product innovation and business expansion to expedite the entire drug development cycle." expressed Dr. Rajan Bawa

Post this

In recent years, Scispot has emerged as a leading digital transformation toolkit in the biotech sector, equipping hundreds of biotechs to function as digital biology companies with automated workflows and interconnected data. Under Dr. Bawa's guidance, Scispot will focus on optimizing in vivo research processes, offering streamlined workflows and AI-prepared data specifically designed for animal research. This initiative will cement Scispot's role as a vital tool for the biotech industry.

"Scispot's mission to fast-track new drug market entries with digital solutions resonates with my career and biotech passion," Dr. Bawa expressed. "I'm excited to contribute to Scispot's efforts, aiming for product innovation and business expansion to expedite the entire drug development cycle."

Guru Singh, Founder & CEO of Scispot, stated, "Dr. Bawa's combination of drug and device R&D expertise and strategic business development background is ideal for guiding us in our next stage of growth. His contributions will assist in our product and business decisions to help us grow even faster."

The inclusion of Dr. Bawa on Scispot's Advisory Board signifies a crucial step towards creating more specialized AI-powered digital solutions for biotechs and CROs, reinforcing the company's position as a leader in the field. His vast experience and strategic vision are expected to drive significant advancements in Scispot's platform.

Looking ahead, Scispot plans to welcome more industry leaders to the Advisory Board, strengthening its mission to blend biology with technology. This initiative signifies Scispot's continued growth and commitment to supercharging biotech and pharma.

ABOUT SCISPOT:
Scispot, the leading provider of biotech tech, is on a mission to transform every biotech company into an AI powerhouse. The company's Gen AI-powered data infrastructure has become the preferred choice for hundreds of digital biotech companies, offering a solid foundation for growth. Scispot automates biotech R&D workflows and makes R&D data AI-ready. Its platform provides one-click integration with scientific applications and instruments, fostering an innovative environment for the development of unique data models and ontologies. This progressive strategy empowers biotech companies to maximize the potential of AI and data science, setting new standards in research and development. Discover more about how Scispot is revolutionizing biotech R&D at http://www.scispot.com

Media Contact

Apoorv Sharma, Scispot, 14255004629, [email protected] , https://scispot.com/ 

Twitter

SOURCE Scispot

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.